Biocompatible
polymers possessing antifouling properties for biomolecules
are necessary to be combined with nanoparticles for cancer chemotherapy
to improve their retention in blood and subsequent tumor accumulation.
However, these properties simultaneously lead to poor affinity to
cells, and low tumor tissue permeability subsequently, which is one
of the major barriers in achieving efficient anticancer efficacy.
To address this, we try to elucidate the tumor permeability of nanoparticles
using molecular bottlebrushes (MBs) as model polymeric nanoparticles
composed of various biocompatible polymers. An MB comprising nonionic
poly[(ethylene glycol) methyl ether methacrylate] (PEGMA) shows no
tumor permeability at all, whereas zwitterionic MBs composed of poly(phosphobetaine
methacrylate), poly(sulfobetaine methacrylate), or poly(carboxybetaine
methacrylate) penetrate deeply into tumor tissues. The carboxybetaine-based
MBs showed an efficient cellular uptake into cancer cells while the
other MBs did not, which enable them to penetrate into tumor tissues
via the transcytosis pathway. Additionally, their permeability is
based on intercellular or intracellular pathways, which might be related
to the zwitterionic betaine properties that recognize protein transporters
on cancer cells. Surprisingly, incorporating only 10 mol % of the
zwitterionic betaine polymers into PEGMA-based MBs significantly enhances
their tissue permeability. This platform technology enables us to
redesign the PEG-based nanoparticles developed for cancer chemotherapy
in clinical applications.